ebasedEVOLUTION

ebasedEVOLUTION is a German biotechnology company specializing in the development of extracellular vesicle (EV) based therapeutics derived from mesenchymal stem cells (MSCs). The company leverages its proprietary 'ebased' platform to produce standardized, high-quality EVs for the treatment of inflammatory and autoimmune disorders. Their lead focus is on Graft-versus-host disease (GvHD), where they aim to provide a cell-free alternative to traditional stem cell therapies. Founded as a spin-off from the University Hospital Essen, the company combines deep academic research with industrial manufacturing standards to address scalability and heterogeneity in the EV field. Their approach seeks to improve safety profiles and therapeutic consistency in regenerative medicine.